EUCTR2008-006775-67-PL进行中（未招募）不适用
A randomised, open-label, assessor-blind, parallel groups, multicentre trial compating the efficacy of MENOOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist protocol and single embryo transfer. - MEGASET
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 660
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Subjects eligible for ICSI, with the primary diagnosis of infertility being unexplained infertility or mild male factor will be included in this trial. Subjects should be 21-34 years old, have a BMI of 18-25 kg/m2, have early follicular FSH levels between 1 and 12 IU/L and antral follicle count = 10, as well as regular menstrual cycles of 24-35 days presumed to be ovulatory. Subjects must be willing to accept transfer of one blastocyst in the fresh cycle, and willing to undergo frozen embryo replacement cycles with transfer of one blastocyst per cycle within the first year after randomisation. Written informed consent must be obtained.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects with known polycystic ovarian syndrome, known endometriosis stage I-IV or diagnosed as poor responders will be excluded.
研究者
相似试验
进行中（未招募）
不适用
A randomised, open-label, assessor-blind, parallel groups, multicentre trial comparing the efficacy of MENOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist protocol and single embryo transfer - MEGASETControlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART)MedDRA version: 9.1Level: LLTClassification code 10021926Term: InfertilityEUCTR2008-006775-67-SEFerring Pharmaceuticals A/S660
进行中（未招募）
不适用
A randomised, open-label, assessor-blind, parallel groups, multicentre trial compating the efficacy of MENOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist protocol and single embryo transfer. - MEGASETControlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART)MedDRA version: 9.1Level: LLTClassification code 10021926Term: InfertilityEUCTR2008-006775-67-BEFerring Pharmaceuticals A/S660
进行中（未招募）
不适用
A randomised, open-label, assessor-blind, parallel groups, multicentre trial compating the efficacy of MENOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist protocol and single embryo transfer. - MEGASETEUCTR2008-006775-67-DKFerring Pharmaceuticals A/S660
进行中（未招募）
不适用
A randomised, open-label, assessor-blind, parallel groups, multicentre trial comparing the efficacy of MENOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist protocol and single embryo transfer - MEGASETControlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART)MedDRA version: 9.1Level: LLTClassification code 10021926Term: InfertilityEUCTR2008-006775-67-CZFerring Pharmaceuticals A/S660
进行中（未招募）
3 期
Comparative study of Recombinant human menopausal gonadotrophin in treatment of infertilityCTRI/2017/11/010317Bharat serums and Vaccines ltd309